COVID-19 vaccines – Global Health Press

Latest Science

Feature: The 2026 vaccine licenses: influenza drives a new platform era

The most revealing feature of vaccine licensure in 2026 is not a newly targeted pathogen. It is the concentration of innovation around familiar respiratory threats: seasonal influenza and COVID-19. Four notable...

23 September, 2026

11 min read

GHP News

ViVa News — Week 27

India — CDSCO digital submission mandate (effective 1 July) From 1 July 2026, India’s Central Drugs Standard Control Organization (CDSCO) requires that all Post-Approval Change applications for human vaccines and...

8 July, 2026

5 min read

GHP News Latest Science

“The worst possible case”:
Robert F. Kennedy Jr.’s impact so far

The article offers an in-depth examination of the sweeping and controversial changes implemented during Kennedy’s tenure as Secretary of Health and Human Services. Kennedy, a polarizing figure, has moved to wind down...

28 August, 2025

2 min read

GHP News Latest Science

Global human challenge consortium to push for next generation of vaccines

An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines. The global consortium will lay the crucial groundwork needed to...

7 April, 2024

5 min read

Latest Science

Which COVID-19 vaccines are in human clinical trials?

In ordinary times, vaccine development, testing and manufacturing is a process that can take several years to complete. In the context of the COVID-19 global pandemic, we are in far from ordinary times. Extreme efforts...

7 August, 2020

5 min read

Tag - COVID-19 vaccines

Feature: The 2026 vaccine licenses: influenza drives a new platform era

ViVa News — Week 27

“The worst possible case”: Robert F. Kennedy Jr.’s impact so far

Global human challenge consortium to push for next generation of vaccines

National vaccine equity is a cornerstone of the success of the Europe’s fight against COVID-19

Which COVID-19 vaccines are in human clinical trials?

“The worst possible case”:
Robert F. Kennedy Jr.’s impact so far